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Cromolyn Sodium Reduces HTS Mast Cell Density
In toluidine blue stained tissues, mast cell  
density decreases in HTS with CS  
treatment to statistically similar densities  
found in non-burned skin. Mast cell  
numbers remained elevated in STSG or  
CS Vehicle treated wounds over 4  
months. *p<0.05, data is presented as  
mean number of mast cells · mm-2 ± SD
➢ Female Red Duroc Pigs
➢ Full-thickness contact burn4
➢ Excision 24hr post-burn
➢ 1:4 split-thickness autograft  
(STSG)
➢ HTS progression confirmed
➢ Biweekly treatment after closure
o 4% Cromolyn Sodium
o Vehicle: Hydrocerin cream
➢ Analyses
o3D Wound Healing and HTS
oMC and Fibrotic histology
oFibrotic signaling proteomics
Post-burn HTS Morphology is Improved with Topical CS
3-Dimensional topographical analysis  
(LifeViz-II, Quantificare) shows  
decreased scar height (inset images)  
over time in CS-treated HTS compared  
to STSG or CS vehicle only treated  
scars after 4 months; scale = 0 (blue) – 5  
mm (red), quantified as percent change.
*p≤0.05, data are presented as mean %  
percent change ± SD.
Topical Cromolyn Reduces HTS Epidermal Hyperplasia
Epidermal Thickness Index (ETI, left): Mean epidermal height was normalized to non-burned skin epidermis at each time point to  
yield ETI. An ETI = 1 is the equivalent thickness of non-burned skin. CS treatment significantly reduced ETI over 4 months.
Reduction in Fibrotic Phenotype Mediated by PAR-2…
HTS Vascularity is Diminished Following CS Treatment
Representative images of CD31 immunostained 4-month biopsies;  
scale bar = 200μm. Topical CS treatment significantly reduced  
dermal HTS vascularity compared to both STSG and CS vehicle  
treatment alone after 4 months post-burn, *p<0.05 No significant  
differences in vascularity were measured prior to 4 months. Data  
are presented as mean vascular density IOD ± SD.
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Painful, motion-limiting hypertrophic scars (HTS) form subsequent to  
protracted wound healing in patients with severe full-thickness burns and  
pose difficult treatment challenges. Newer evidence points to mast cells  
(MC) as important regulators of intricate signaling cascades during the  
initiation and progression of post-burn scars. Previous investigations have  
demonstrated increased mast cell densities in burn wounds and during the  
formation of HTS.1,2 Mast cells release a wide array of mitogenic cytokines  
and potent proteases that contribute directly to myofibroblast differentiation  
and excessive proliferation in burn wounds; further prolonging fibrotic  
pathology.3 Cromolyn sodium (CS) is an FDA-approved mast cell  stabilizer 
known to inhibit degranulation and has been successfully used to  relieve 
detrimental symptoms associated with mast cell activation. Here, we  show 
that CS may be an effective conjunctive therapy to prevent  pathological 
fibrosis following severe burn injury.
Adapted from Hart, DA. 2017.  
Targeting Mast Cells as a  
Viable Therapeutic Option in  
Endometriosis. Eur Med J.
CS Treatment Reduces Dermal Collagen Density
Dermal collagen density (right): Collagen density was assessed by integrated optical density of trichrome stained skin and  
scar biopsies. Topical CS treatment reduced collagen density in post-burn HTS after 4-months compared to STSG alone or  
vehicle.
• Cromolyn sodium improves post-burn wound healing by  
reducing mast cell density and reduces subsequent  
collagen deposition in the healing wound.
• Mast cell stabilization with topical cromolyn sodium  
reduces HTS pathophysiology and may provide beneficial  
adjuvant anti-scarring therapy following a severe burn.
